Impaired liver function and retroviral activity are risk factors contributing to HIV-associated thrombocytopenia

AIDS

Volumn 13, Issue 14, 1999, Pages 1913-1920

  Ciernik, Ilja F ^a,b   Cone, Richard W ^a   Fehr, Jörg ^a   Weber, Rainer ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antiviral therapy; Autoimmunity; HIV; Idiopathic thrombocytopenic purpura; Liver disease; Megakaryocyte growth factor; Retroviruses; Thrombocytopenia; Thrombopoietin; Viral infection; Viral replication

Indexed keywords

ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; THROMBOPOIETIN; VIRUS RNA;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; HEPATOMEGALY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS REPLICATION;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HEMORRHAGE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTE COUNT; LIVER; LIVER FUNCTION TESTS; MALE; PLATELET COUNT; RISK FACTORS; SPLENOMEGALY; THROMBOCYTOPENIA; THROMBOPOIETIN; VIRAL LOAD;

EID: 0032708973     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199910010-00014     Document Type: Article

References (41)

1. Chelucci C, Federico M, Guerriero R, et al. Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 1998, 91:1225-1234.
2. Wang JF, Liu ZY, Groopman JE. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion. Blood 1998, 92:756-764.
3. Schwartz GN, Kessler SW, Rothwell SW, et al. Inhibitory effects of HIV-1 infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. (erratum in 23:181). Exp Hematol 1994, 22:1288-1296.
4. Cole JL, Marzec UM, Gunthel CJ, et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 1998, 91:3239-3246.
5. Hohmann AW, Booth K, Peters V, Gordon DL, Comaccio RM. Common epitope of HIV p24 and human platelets. Lancet 1993, 342:1274-1275.
6. Sungaran R, Markovic B and Chong BH. Localisation and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridisation. Blood 1997, 89:101-107.
7. McCarty JM, Sprugel KH, Fox NE, Sabath DE, Kaushansky K. Murine thrombopoietin mRNA levels are modulated by platelet count Blood 1995, 86:3668-3675.
8. Hou M, Carneskog J, Mellqvist U-H, et al. Impact of endogenous thrombopoietin levels on the differential diagnosis of essential thrombocytopenia and reactive thrombocytosis. Eur J Haematol 1998, 61:119-122.
9. Kaushansky K, Broudy VC, Lin N, et al. Thrombopoietin, the mpl-ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995, 92:3234-3238.
10. Debili N, Wendung F, Katz A, et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities in human megakaryocyte progenitors. Blood 1995, 86:2516-2525.
11. Bunting S, Widmer R, Lipari T, et al. Normal platelet and megakaryocytes are produced in vivo in the absence of thrombopoietin. Blood 1997, 90:3423-3429.
12. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995, 85:2720-2730.
13. Folman CC, von dem Borne AECK, Rensink IHJAM, et al. Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thromb Haemost 1997, 78:1262-1267.
14. Fielder PJ, Mass P, Nagel M, et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997, 89:2782.
15. Handagama PJ, George JN, Shuman MA, McEver RP, Bainton DF. Incorporation of a circulation protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA 1987, 84:861-865.
16. Porcelijn L, Folman CC, Bossers B, et al. The diagnostic value of thrombopoietin level measurements in thrombocytopenia. Thromb Haemost 1998, 79:1101-1105.
17. de Sauvage FJ, Villeval J-L, Shivdasani RA. Regulation of megakaryocytopoiesis and platelet production: lessons from animal models. J Lab Clin Med 1998, 131:496-501.
18. Hirayama Y, Sakamaki S, Matsunaga T, et al. Concentrations of thrombopoietin in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells. Blood 1998, 92:46-51.
19. Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoietin in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 1998, 79:1106-1110.
20. Cerutti A, Custodi P, Duranti M, Noris P, Badluini CL. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Br J Haematol 1997, 99:281-284.
21. Martin III TC, Somberg KA, Meng YC, et al. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transpantation. Ann Intern Med 1997, 127:285-288.
22. Ledergerber B, von Overbeck J, Egger M, Lüthy R. The Swiss HIV cohort study: rational, organization, and selected baseline characteristics. Soz Präventivmed 1994, 39:387-394.
23. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicenter study. Br Med J 1997, 315:1194-1199.
24. Behr T, Bair H-J, Becker W, Wolf F, Schwab J. Aetiology of HIV-associated thrombocytopenia. Lancet 1994, 343:479.
25. Walsh C, Kriegel R, Lennette E, Karpatkin S. Thrombocytopenia in homosexual patients. Ann Intern Med 1985, 103:542-545.
26. Kaslow RA, Phair JP, Friedman HB, et al. Infection with the human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. Ann Intern Med 1987, 107:474-480.
27. 1993 revised CDC HIV classification and expanded AIDS surveillance definition for adolescents and adults. MMRW 1992, 41:RR-17.
28. Swiss Croup for clinical studies on the acquired immunodeficiency syndrome. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). Ann Intern Med 1988, 109:718-721.
29. Oksenhendler E, Bierling P, Ferchal F, Clauvel J-P, Seligmann M. Zidovudine for thrombocytopenic purpura related to human immunodeficiency virus (HIV) infection. Ann Intern Med 1989, 110:365-368.
30. Ballem PJ, Belzberg A, Devine DV, et al. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 1992, 327:1779-1784.
31. Pechere M, Samii K, Hirschel B. HIV-related thrombocytopenia. N Engl J Med 1993, 329:1785-1786.
32. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic immunity. Cell 1996, 87:811-822.
33. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependant diabetes mellitus in a transgenic model. Cell 1991, 65:319-331.
34. Frosch S, Bonifas U, Eck H-P, et al. The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with a high level of intracellular reducing thiols. Eur J Immunol 1993, 23:1430-1441.
35. Aichele P, Bachmann MF, Hengartner H, Zinkernagel RM. Immunopathology and organ-specific autoimmunity as a consequence of virus infection. Immunol Rev 1996, 152:21-45.
36. Eddleston ALWF. Hepatits C and autoimmunity. J Hepatol 1996, 24 (suppl):55-60.
37. Lunardi C, Tiso M, Borgato L, et al. Chronic parvovirus B19 infection induces the production of antivirus antibodies with autoantigen binding properties. Eur J Immunol 1998, 28:936-948.
38. Nakagawa K, Harrison LC. The potential roles of endogenous retroviruses in autoimmunity. Immunol Rev 1996, 152:193-256.
39. Yoshiki T, Mellors RC, Strand M, August JT. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974, 140:1011-1027.
40. Berberian L, Googlick L, Kipps TJ, Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 1993, 261:1588-1589.
41. Bisset LR, Cone RW, Huber W, et al. Highly active antiretroviral therapy during early HIV-infection reverses T-cell activation and maturation. AIDS 1998, 12:2115-2123.